{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T05:33:02Z","timestamp":1789623182192,"version":"build-2803163510"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.jaut.2020.102507","type":"journal-article","created":{"date-parts":[[2020,6,24]],"date-time":"2020-06-24T09:15:30Z","timestamp":1592990130000},"page":"102507","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Autoimmunity to neuroretina in the concurrent absence of IFN-\u03b3 and IL-17A is mediated by a GM-CSF-driven eosinophilic inflammation"],"prefix":"10.1016","volume":"114","author":[{"given":"So Jin","family":"Bing","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phyllis B.","family":"Silver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingyos","family":"Jittayasothorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary J.","family":"Mattapallil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Chao","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reiko","family":"Horai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7140-7671","authenticated-orcid":false,"given":"Rachel R.","family":"Caspi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2020.102507_bib1","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1172\/JCI42440","article-title":"A look at autoimmunity and inflammation in the eye","volume":"120","author":"Caspi","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jaut.2020.102507_bib2","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1749-6632.2009.05133.x","article-title":"Th1 and Th17 cells: adversaries and collaborators","volume":"1183","author":"Damsker","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jaut.2020.102507_bib3","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1006\/clim.1999.4701","article-title":"Expression of interferon-gamma in the lens exacerbates anterior uveitis and induces retinal degenerative changes in transgenic Lewis rats","volume":"91","author":"Egwuagu","year":"1999","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jaut.2020.102507_bib4","doi-asserted-by":"crossref","first-page":"510","DOI":"10.4049\/jimmunol.162.1.510","article-title":"IFN-gamma increases the severity and accelerates the onset of experimental autoimmune uveitis in transgenic rats","volume":"162","author":"Egwuagu","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2020.102507_bib5","doi-asserted-by":"crossref","first-page":"5997","DOI":"10.4049\/jimmunol.158.12.5997","article-title":"IFN-gamma-deficient mice develop experimental autoimmune uveitis in the context of a deviant effector response","volume":"158","author":"Jones","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2020.102507_bib6","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1002\/eji.1830260735","article-title":"Interferon-\u03b3 confers resistance to experimental allergic encephalomyelitis","volume":"26","author":"Krakowski","year":"1996","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jaut.2020.102507_bib7","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4049\/jimmunol.156.1.5","article-title":"Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE)","volume":"156","author":"Ferber","year":"1996","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2020.102507_bib8","doi-asserted-by":"crossref","first-page":"890","DOI":"10.4049\/jimmunol.152.2.890","article-title":"Endogenous systemic IFN-gamma has a protective role against ocular autoimmunity in mice","volume":"152","author":"Caspi","year":"1994","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2020.102507_bib9","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00281-008-0108-5","article-title":"New perspectives on effector mechanisms in uveitis","volume":"30","author":"Luger","year":"2008","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.jaut.2020.102507_bib10","doi-asserted-by":"crossref","first-page":"566","DOI":"10.4049\/jimmunol.177.1.566","article-title":"IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis","volume":"177","author":"Komiyama","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2020.102507_bib11","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.cellimm.2005.11.002","article-title":"Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis","volume":"237","author":"Hofstetter","year":"2005","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.jaut.2020.102507_bib12","doi-asserted-by":"crossref","first-page":"6173","DOI":"10.4049\/jimmunol.171.11.6173","article-title":"Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice","volume":"171","author":"Nakae","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2020.102507_bib13","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/nm1585","article-title":"TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27\/STAT1","volume":"13","author":"Amadi-Obi","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.jaut.2020.102507_bib14","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1084\/jem.20041257","article-title":"IL-23 drives a pathogenic T cell population that induces autoimmune inflammation","volume":"201","author":"Langrish","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jaut.2020.102507_bib15","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1084\/jem.20071258","article-title":"Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category","volume":"205","author":"Luger","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jaut.2020.102507_bib16","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/ni.1993","article-title":"Fate mapping of IL-17-producing T cells in inflammatory responses","volume":"12","author":"Hirota","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jaut.2020.102507_bib17","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S1074-7613(02)00391-6","article-title":"Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses","volume":"17","author":"Nakae","year":"2002","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2020.102507_bib18","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.immuni.2008.11.009","article-title":"Differential roles of interleukin-17A and -17F in host defense against mucoepithelial bacterial infection and allergic responses","volume":"30","author":"Ishigame","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2020.102507_bib19","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1084\/jem.20071836","article-title":"Strain-specific requirement for eosinophils in the recruitment of T cells to the lung during the development of allergic asthma","volume":"205","author":"Walsh","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jaut.2020.102507_bib20","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1084\/jem.20020656","article-title":"Targeted deletion of a high-affinity GATA-binding site in the GATA-1 promoter leads to selective loss of the eosinophil lineage in vivo","volume":"195","author":"Yu","year":"2002","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jaut.2020.102507_bib21","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/j.1751-1097.1991.tb02129.x","article-title":"Functional properties OF interphotoreceptor retinoid-binding protein*","volume":"54","author":"Pepperberg","year":"1991","journal-title":"Photochem. Photobiol."},{"key":"10.1016\/j.jaut.2020.102507_bib22","doi-asserted-by":"crossref","first-page":"5439","DOI":"10.1167\/iovs.15-17280","article-title":"Characterization of a new epitope of IRBP that induces moderate to severe uveoretinitis in mice with H-2b haplotype","volume":"56","author":"Mattapallil","year":"2015","journal-title":"Investig. Ophthalmol. Visual Sci."},{"key":"10.1016\/j.jaut.2020.102507_bib23","doi-asserted-by":"crossref","first-page":"36626","DOI":"10.1074\/jbc.M006613200","article-title":"Identification of potent, selective non-peptide CC chemokine receptor-3 antagonist that inhibits eotaxin-, eotaxin-2-, and monocyte chemotactic protein-4-induced eosinophil migration","volume":"275","author":"White","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.jaut.2020.102507_bib24","first-page":"15.6.1","article-title":"Experimental autoimmune uveoretinitis in the rat and mouse","volume":"53","author":"Caspi","year":"2003","journal-title":"Curr. Protoc. Im."},{"key":"10.1016\/j.jaut.2020.102507_bib25","doi-asserted-by":"crossref","first-page":"550","DOI":"10.2174\/1566524015666150731100318","article-title":"Mouse models of experimental autoimmune uveitis: comparative analysis of adjuvant-induced vs spontaneous models of uveitis","volume":"15","author":"Chen","year":"2015","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.jaut.2020.102507_bib26","doi-asserted-by":"crossref","first-page":"4004","DOI":"10.4049\/jimmunol.181.6.4004","article-title":"Functionally competent eosinophils differentiated ex vivo in high purity from normal mouse bone marrow","volume":"181","author":"Dyer","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2020.102507_bib27","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1006\/exer.2000.0860","article-title":"Residues 1\u201320 of IRBP and whole IRBP elicit different uveitogenic and immunological responses in interferon gamma deficient mice","volume":"71","author":"Avichezer","year":"2000","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.jaut.2020.102507_bib28","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/intimm\/dxm135","article-title":"Differential roles for IFN-gamma and IL-17 in experimental autoimmune uveoretinitis","volume":"20","author":"Yoshimura","year":"2008","journal-title":"Int. Immunol."},{"key":"10.1016\/j.jaut.2020.102507_bib29","doi-asserted-by":"crossref","first-page":"4616","DOI":"10.1167\/iovs.07-0233","article-title":"Altered chemokine profile associated with exacerbated autoimmune pathology under conditions of genetic interferon-gamma deficiency","volume":"48","author":"Su","year":"2007","journal-title":"Investig. Ophthalmol. Visual Sci."},{"key":"10.1016\/j.jaut.2020.102507_bib30","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1073\/pnas.261462598","article-title":"The murine CCR3 receptor regulates both the role of eosinophils and mast cells in allergen-induced airway inflammation and hyperresponsiveness","volume":"99","author":"Humbles","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.jaut.2020.102507_bib31","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nrd3838","article-title":"Targeting eosinophils in allergy, inflammation and beyond","volume":"12","author":"Fulkerson","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jaut.2020.102507_bib32","first-page":"121","article-title":"GM-CSF regulation in eosinophils","volume":"50","author":"Esnault","year":"2002","journal-title":"Arch. Immunol. Ther. Exp."},{"key":"10.1016\/j.jaut.2020.102507_bib33","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1093\/intimm\/dxp102","article-title":"IL-5- and eosinophil-mediated inflammation: from discovery to therapy","volume":"21","author":"Kouro","year":"2009","journal-title":"Int. Immunol."},{"key":"10.1016\/j.jaut.2020.102507_bib34","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1189\/jlb.1106686","article-title":"Eosinophils develop in distinct stages and are recruited to peripheral sites by alternatively activated macrophages","volume":"81","author":"Voehringer","year":"2007","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.jaut.2020.102507_bib35","doi-asserted-by":"crossref","first-page":"4061","DOI":"10.4049\/jimmunol.150.9.4061","article-title":"Increased expression of CD11b and functional changes in eosinophils after migration across endothelial cell monolayers","volume":"150","author":"Walker","year":"1993","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2020.102507_bib36","doi-asserted-by":"crossref","first-page":"5332","DOI":"10.1093\/emboj\/20.19.5332","article-title":"IL-17s adopt a cystine knot fold: structure and activity of a novel cytokine, IL-17F, and implications for receptor binding","volume":"20","author":"Hymowitz","year":"2001","journal-title":"EMBO J."},{"key":"10.1016\/j.jaut.2020.102507_bib37","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1084\/jem.20071978","article-title":"Regulation of inflammatory responses by IL-17F","volume":"205","author":"Yang","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jaut.2020.102507_bib38","first-page":"61","article-title":"IL-17A and IL-17F do not contribute vitally to autoimmune neuro-inflammation in mice","volume":"119","author":"Haak","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jaut.2020.102507_bib39","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1089\/jir.2011.0042","article-title":"Cytokines in autoimmune uveitis","volume":"31","author":"Horai","year":"2011","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.jaut.2020.102507_bib40","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1042\/BJ20101132","article-title":"Pease. Targeting chemokine receptors in allergic disease","volume":"434","author":"James","year":"2011","journal-title":"Biochem. J."},{"key":"10.1016\/j.jaut.2020.102507_bib41","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1517\/17460441.2014.897324","article-title":"Recent progress in the development of antagonists to the chemokine receptors CCR3 and CCR4","volume":"9","author":"Pease","year":"2014","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.jaut.2020.102507_bib42","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nature08151","article-title":"CCR3 is a target for age-related macular degeneration diagnosis and therapy","volume":"460","author":"Takeda","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2020.102507_bib43","first-page":"429","article-title":"Essential mechanisms of differential activation of eosinophils by IL-3 compared to GM-CSF and IL-5","volume":"36","author":"Esnault","year":"2016","journal-title":"Crit. Rev. Immunol."},{"key":"10.1016\/j.jaut.2020.102507_bib44","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/sj.cr.7310017","article-title":"Granulocyte-macrophage colony-stimulating factor (GM-CSF) and T-cell responses: what we do and don't know","volume":"16","author":"Shi","year":"2006","journal-title":"Cell Res."},{"key":"10.1016\/j.jaut.2020.102507_bib45","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.3389\/fimmu.2019.02679","article-title":"The pleiotropic effects of the GM-CSF rheostat on myeloid cell differentiation and function: more than a numbers game","volume":"10","author":"Zhan","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2020.102507_bib46","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/ni.2027","article-title":"RORgammat drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation","volume":"12","author":"Codarri","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jaut.2020.102507_bib47","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/ni.2031","article-title":"The encephalitogenicity of T(H)17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF","volume":"12","author":"El-Behi","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jaut.2020.102507_bib48","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.92362","article-title":"GM-CSF is not essential for experimental autoimmune encephalomyelitis but promotes brain-targeted disease","volume":"2","author":"Pierson","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.jaut.2020.102507_bib49","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1126\/science.8171324","article-title":"Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis","volume":"264","author":"Dranoff","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.jaut.2020.102507_bib50","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.immuni.2019.04.006","article-title":"Fate-Mapping of GM-CSF expression identifies a discrete subset of inflammation-driving T helper cells regulated by cytokines IL-23 and IL-1beta","volume":"50","author":"Komuczki","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2020.102507_bib51","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.immuni.2017.01.007","article-title":"Dysregulation of the cytokine GM-CSF induces spontaneous phagocyte invasion and immunopathology in the central nervous system","volume":"46","author":"Spath","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2020.102507_bib52","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1084\/jem.189.2.219","article-title":"Interleukin 12 protects from a T helper type 1-mediated autoimmune disease, experimental autoimmune uveitis, through a mechanism involving interferon gamma, nitric oxide, and apoptosis","volume":"189","author":"Tarrant","year":"1999","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jaut.2020.102507_bib53","doi-asserted-by":"crossref","first-page":"4791","DOI":"10.4049\/jimmunol.181.7.4791","article-title":"Activation of invariant NKT cells ameliorates experimental ocular autoimmunity by a mechanism involving innate IFN-gamma production and dampening of the adaptive Th1 and Th17 responses","volume":"181","author":"Grajewski","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2020.102507_bib54","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1084\/jem.20141678","article-title":"NK-DC crosstalk controls the autopathogenic Th17 response through an innate IFN-gamma-IL-27 axis","volume":"212","author":"Chong","year":"2015","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jaut.2020.102507_bib55","first-page":"758","article-title":"Induction of ocular inflammation by T-helper lymphocytes type 2","volume":"43","author":"Kim","year":"2002","journal-title":"Investig. Ophthalmol. Visual Sci."},{"key":"10.1016\/j.jaut.2020.102507_bib56","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.MCHD-0020-2015","article-title":"The regulatory function of eosinophils","volume":"4","author":"Wen","year":"2016","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.jaut.2020.102507_bib57","doi-asserted-by":"crossref","first-page":"484","DOI":"10.3389\/fimmu.2017.00484","article-title":"Eosinophils in autoimmune diseases","volume":"8","author":"Diny","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2020.102507_bib58","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.ophtha.2012.09.040","article-title":"Secukinumab in the treatment of noninfectious uveitis: results of three randomized, controlled clinical trials","volume":"120","author":"Dick","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jaut.2020.102507_bib59","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s41232-016-0014-5","article-title":"GM-CSF as a therapeutic target in autoimmune diseases","volume":"36","author":"Shiomi","year":"2016","journal-title":"Inflamm. Regen."}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841120301293?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841120301293?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:27:06Z","timestamp":1760257626000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841120301293"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":59,"alternative-id":["S0896841120301293"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2020.102507","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoimmunity to neuroretina in the concurrent absence of IFN-\u03b3 and IL-17A is mediated by a GM-CSF-driven eosinophilic inflammation","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2020.102507","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102507"}}